Payers

MedPAC has argued for Medicare drug pricing reforms for several years, and federal agencies often take their recommendations seriously. But industry opposition has been the primary roadblock to several MedPAC proposals.

In fact, the proposed drug price negotiation program does not authorize the federal government to decide which medications people on Medicare can and cannot get and does not establish or require a particular prescription drug formulary.

Medicare and a host of other federal agencies are prohibited by law from accessing this kind of purchasing power.

The B.C. government has also announced a new provincially co-ordinated model of care for cystic fibrosis patients.

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available on the NHS for sickle cell disease.

You can estimate your drug costs at Medicare.gov/plan-compare.

Medicaid’s pharmacy director says the Biogen Alzheimer’s drug is ‘currently a covered outpatient drug.

Attorney General Leslie Rutledge announced today a $15.2 million settlement with Centene Corporation and three subsidiaries for overcharging the state Medicaid program for medication.

The body in charge of pricing and reimbursement in Germany has downgraded the extent of additional benefit offered by Gilead’s Veklury for treating COVID-19 patients.

The province is part of the pan-Canadian Pharmaceutical Alliance (pCPA), which has been engaged in negotiations with Vertex Pharmaceuticals for months.

3 provinces will pay to provide eligible patients with Trikafta, which costs roughly $300K a year.

The lawsuits claim a generic version ultimately entered the market in December 2016 when one could have launched years earlier in December 2011.

Instead of relying on price regulation, Canada should engage in negotiations about drug pricing.

Chimeric antigen receptor T-cell (CAR-T) therapies have been changing the cancer treatment landscape.

China releases draft regulations from country's Center for Drug Evaluation on Patient-Reported-Outcomes.